| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
, RAR
, and RAR
1
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs)
are thought to mediate most of the effects of retinoids on cell growth
and differentiation. Despite expressing abundant levels of RARß mRNA,
lung adenocarcinoma H1792 cells are resistant to the growth-inhibitory
effects of all-trans-retinoic acid, suggesting that they
have a defect in retinoid signaling. To determine whether transfection
of exogenous receptors can restore retinoid responsiveness, we
transiently transfected into H1792 cells coexpression vectors
containing cDNAs of cell surface antigen CD7 and either RAR
, RARß,
RAR
, or RXR
. The cells were then treated with retinoids and
incubated with 5'-bromo-2'deoxyuridine. Cells that express
exogenous receptor were identified using antibodies against CD7, and
cells that synthesized DNA were identified with
anti-5'-bromo-2'-deoxyuridine antibodies using secondary antibodies
with red and green fluorescence, respectively. RXR
and RAR
enhanced growth inhibition by all-trans-retinoic acid or
9-cis-retinoic acid, whereas RAR
was less effective,
and RARß was ineffective. The effects of the transfected receptors
were associated with antagonism of activator protein 1 (AP-1) activity.
Studies with RXR
deletion and point mutants indicated that growth
suppression is: (a) dependent on intact DNA-binding and
ligand-binding regions but not on the NH2-terminal region,
which contains a ligand-independent transactivation function;
(b) dependent on RXR homodimer formation and
transactivation of RXR response element; and (c)
associated with AP-1 antagonism. These results demonstrate that
transfected receptors can restore responsiveness to retinoids by
antagonizing AP-1 in H1792 cells.
This article has been cited by other articles:
![]() |
H. Srinivas, D. M. Juroske, S. Kalyankrishna, D. D. Cody, R. E. Price, X.-C. Xu, R. Narayanan, N. L. Weigel, and J. M. Kurie c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor {alpha} Mol. Cell. Biol., February 1, 2005; 25(3): 1054 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Soria, X. Xu, D. D. Liu, J. J. Lee, J. Kurie, R. C. Morice, F. Khuri, L. Mao, W. K. Hong, and R. Lotan Retinoic Acid Receptor {beta} and Telomerase Catalytic Subunit Expression in Bronchial Epithelium of Heavy Smokers J Natl Cancer Inst, January 15, 2003; 95(2): 165 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vivat-Hannah, D. You, C. Rizzo, J.-P. Daris, P. Lapointe, F. C. Zusi, A. Marinier, M. V. Lorenzi, and M. M. Gottardis Synergistic Cytotoxicity Exhibited by Combination Treatment of Selective Retinoid Ligands with Taxol (Paclitaxel) Cancer Res., December 1, 2001; 61(24): 8703 - 8711. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hatoum, M. E. El-Sabban, J. Khoury, S. H. Yuspa, and N. Darwiche Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis Carcinogenesis, December 1, 2001; 22(12): 1955 - 1963. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |